Hemodynamic Monitoring Enters a New Era
Executive Summary
As critical care migrates from intensive care units to other areas of the hospital, hemodynamic monitors--essential for patient diagnosis and prognosis--must make the move as well. At this year's annual meeting of the Society of Critical Care Medicine, clinicians and researchers discussed the need and the market challenges for hemodynamic monitoring technologies that are simpler to use, less invasive and allow for earlier diagnosis of sepsis and shock.
You may also be interested in...
Recent Trends in Hemodynamic Monitoring
Growth in the hemodynamic monitoring market is being fueled by several factors, including the aging population and the increasing demand for less invasive and noninvasive technologies for measuring global parameters of oxygen delivery. While barriers to entry are high in the hemodynamic monitoring business, the prospect for future growth is significant.
Recent Trends in Hemodynamic Monitoring
Growth in the hemodynamic monitoring market is being fueled by several factors, including the aging population and the increasing demand for less invasive and noninvasive technologies for measuring global parameters of oxygen delivery. While barriers to entry are high in the hemodynamic monitoring business, the prospect for future growth is significant.
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q1 2008
The first quarter of 2008 saw a dearth in financings for both the medical device and in vitro diagnostics segments. In the former, volume fell short of the billion dollar mark while the latter failed to reach the success the previous quarter had witnessed, despite completing an equal number of transactions. M&A in medical devices didn't look any more promising, bringing in $1.6 billion, a huge slide from the impressive $10 billion total of 2007's fourth quarter. However, there was one bright spot: acquisitions within in vitro diagnostics/research reagents substantially increased to $3.1 billion from the $370 million spent in the previous three months, led by Inverness Medical Innovations' $1.1 billion takeover of Matria Healthcare Inc. Also noteworthy: oncology diagnostics alliances grew slowly and steadily thanks to increasing attention from larger companies.